Sales momentum accelerated significantly in H1, led by broad-based growth across businesses. While wholesale benefited from the success of Marvel, the momentum in cochlear implants was driven by the MRI-compatible implant. Retail was fuelled by effective lead generation management and in-store execution, leading to the financial guidance upgrade for FY19/20. Nonetheless, higher than expected R&D and sales and marketing expenses and a new restructuring charge took away some of the sheen.
21 Nov 2019
Sales beat in H1 while profitability misses the bus; full-year outlook raised
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Sales beat in H1 while profitability misses the bus; full-year outlook raised
Sonova Holding AG (0QPY:LON) | 0 0 0.7% | Mkt Cap: 9,662m
- Published:
21 Nov 2019 -
Author:
Sumit Sayal -
Pages:
4
Sales momentum accelerated significantly in H1, led by broad-based growth across businesses. While wholesale benefited from the success of Marvel, the momentum in cochlear implants was driven by the MRI-compatible implant. Retail was fuelled by effective lead generation management and in-store execution, leading to the financial guidance upgrade for FY19/20. Nonetheless, higher than expected R&D and sales and marketing expenses and a new restructuring charge took away some of the sheen.